Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

1.55
Delayed Data
As of Jul 27
 +0.11 / +7.64%
Today’s Change
1.23
Today|||52-Week Range
20.45
-84.65%
Year-to-Date

Today’s Trading

Previous close1.44
Today’s open1.41
Day’s range1.41 - 1.55
Volume417,021
Average volume (3 months)864,117
Market cap$42.5M
Dividend yield--
Data as of 07/27/2016

Growth & Valuation

Earnings growth (last year)-88.89%
Earnings growth (this year)-66.86%
Earnings growth (next 5 years)+15.84%
Revenue growth (last year)+51.47%
P/E ratioNM
Price/Sales1.21
Price/Book0.37

Competitors

 Today’s
change
Today’s
% change
VSTMVerastem Inc+0.03+2.36%
PZRXPhaseRx Inc0.000.00%
FATEFate Therapeutics In...+0.14+8.09%
CLBSCaladrius Bioscience...0.000.00%
Data as of 07/27/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$239.9M
Annual profit (last year)-$73.3M
Net profit margin-30.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs